Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1
Authors:
- 15 April 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (8) , 3364-3373
Abstract
Phenoxodiol, an isoflavone derivative of genistein with unknown mechanism of action, is currently being evaluated in early human cancer clinical trials. To determine the mechanism of antiproliferative effects of phenoxodiol, we examined its effects in a battery of human cell lines. Although we observed caspase-dependent apoptosis in HN12 cells as early as 24 hours after exposure, clonogenic death occurred only after 48-hour exposure despite caspase blockade by the general caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (ZVAD)-fmk. Moreover, clear evidence of cell death as determined by nuclear morphology and plasmatic membrane damage occur despite ZVAD, suggesting that another mechanism besides caspase-dependent apoptosis is required for clonogenic death induced by phenoxodiol. In search for other potential antiproliferative effects, we assessed the effects of phenoxodiol in the cell cycle progression of human carcinoma cell lines. A significant G1-S arrest was observed by 12 hours of exposure in HN12 cell lines at concentrations ≥5 μg/mL. Cell cycle arrest occurred several hours (∼12 hours) before induction of apoptosis. Analysis of in vitro purified cyclin-dependent kinase (cdk) activity showed that phenoxodiol did not inhibit cdk activity. In contrast, cellular cdk2 activity obtained from HN12 cell lines exposed to phenoxodiol for 12 hours decreased by 60%, whereas cdk6 activity remained unaltered, suggesting that the loss of cdk2 activity was specific. Loss in cdk2 activity was preceded by the accumulation of the endogenous cdk inhibitor p21WAF1. To assess the role of p21WAF1 induction by phenoxodiol, we used HCT116 isogenic cell lines and showed that phenoxodiol induced G1 arrest together with p21WAF1 expression in wild-type clones. In contrast, p21−/− variants failed to show G1 arrest. Finally, induction of p21 by phenoxodiol is p53 independent, as phenoxodiol induced p21 in HCT116 lacking p53. These data therefore indicate that phenoxodiol promotes G1-S arrest by the specific loss in cdk2 activity due to p53-independent p21WAF1 induction. This novel feature of phenoxodiol may have clinical implications, as the majority of human malignancies have aberrations in cell cycle progression regulation.Keywords
This publication has 43 references indexed in Scilit:
- Paraptosis: mediation by MAP kinases and inhibition by AIP-1/AlixCell Death & Differentiation, 2004
- UCN-01-Induced Cell Cycle Arrest Requires the Transcriptional Induction of p21waf1/cip1 by Activation of Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase PathwayCancer Research, 2004
- CNIO Cancer Conference: Targeted Search for Anticancer DrugsExpert Opinion on Investigational Drugs, 2003
- Second Symposium of Novel Molecular Targets for Cancer TherapyThe Oncologist, 2002
- First Symposium of Novel Molecular Targets for Cancer TherapyThe Oncologist, 2001
- Genistein‐induced G2‐m arrest, P21WAF1upregulation, and apoptosis in a non‐small‐cell lung cancer cell lineNutrition and Cancer, 1998
- Cancer Cell CyclesScience, 1996
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993